相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Statistical Framework for Decision Making in Confirmatory Multipopulation Tailoring Clinical Trials
Brian A. Millen et al.
DRUG INFORMATION JOURNAL (2012)
ETHNIC SENSITIVE OR MOLECULAR SENSITIVE BEYOND ALL REGIONS BEING EQUAL IN MULTIREGIONAL CLINICAL TRIALS
Sue-Jane Wang et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Individual Patient Data Subgroup Meta-Analysis of Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage
Barbara A. Gregson et al.
STROKE (2012)
Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials
Sue-Jane Wang et al.
CLINICAL TRIALS (2010)
Consideration of regional difference in design and analysis of multi-regional trials
H. M. James Hung et al.
PHARMACEUTICAL STATISTICS (2010)
Adaptive patient enrichment designs in therapeutic trials
Sue-Jane Wang et al.
BIOMETRICAL JOURNAL (2009)
Optimizing Trial Design Sequential, Adaptive, and Enrichment Strategies
Cyrus Mehta et al.
CIRCULATION (2009)
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast Cancer
Stephen Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
Werner Brannath et al.
STATISTICS IN MEDICINE (2009)
K-Ras Mutations Are Changing Practice in Advanced Colorectal Cancer
Caroline McNeil
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events
Sara Hughes et al.
PHARMACEUTICAL STATISTICS (2008)
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
Sue-Jane Wang et al.
PHARMACEUTICAL STATISTICS (2007)
Use of genomic signatures in therapeutics development in oncology and other diseases
R. Simon et al.
PHARMACOGENOMICS JOURNAL (2006)
Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
B Freidlin et al.
CLINICAL CANCER RESEARCH (2005)
Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levrofloxacin 750 mg
FJ Martinez et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Multiplicity in randomised trials II: subgroup and interim analyses
KF Schulz et al.
LANCET (2005)
Treating Individuals 2 - Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
PM Rothwell
LANCET (2005)
Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test
ST Brookes et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial
H Wedel et al.
AMERICAN HEART JOURNAL (2001)
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001
A Louis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
分享论文
